Sarcoma News and Research

RSS
UT Southwestern investigators develop new strategy to classify cancers caused by KRAS mutations

UT Southwestern investigators develop new strategy to classify cancers caused by KRAS mutations

UT Southwestern surgeons help pioneer minimally invasive ear surgery

UT Southwestern surgeons help pioneer minimally invasive ear surgery

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

Surgeons use 3D printed implant in patient diagnosed with chest wall sarcoma

Surgeons use 3D printed implant in patient diagnosed with chest wall sarcoma

American Income Life donates $10,000 to Sarcoma Foundation of America

American Income Life donates $10,000 to Sarcoma Foundation of America

CHAM, AECC receive $1.3 million NCI grant to advance more effective bone cancer treatments for children

CHAM, AECC receive $1.3 million NCI grant to advance more effective bone cancer treatments for children

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Discovery could open up door for cancer research and treatment

Discovery could open up door for cancer research and treatment

New NCCN Guidelines for Patients and NCCN Quick Guide for Kidney Cancer published

New NCCN Guidelines for Patients and NCCN Quick Guide for Kidney Cancer published

Landmark 'basket study' shows efficacy of vemurafenib in multiple nonmelanoma BRAFV600-mutated cancers

Landmark 'basket study' shows efficacy of vemurafenib in multiple nonmelanoma BRAFV600-mutated cancers

Organ transplant recipients more likely to develop melanoma

Organ transplant recipients more likely to develop melanoma

Researchers show how realistic environments affect growth of cancer tumors in bones

Researchers show how realistic environments affect growth of cancer tumors in bones

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

Daiichi Sankyo, Plexxikon’s Phase 1 trial shows PLX3397 induced prolonged tumor regression in TGCT patients

Daiichi Sankyo, Plexxikon’s Phase 1 trial shows PLX3397 induced prolonged tumor regression in TGCT patients

Research brief provides clinical validation of LOXO-101 Phase 1 trial for treatment of TRK fusion cancer

Research brief provides clinical validation of LOXO-101 Phase 1 trial for treatment of TRK fusion cancer

LMU researchers reveal role of mutations in development of Ewing's sarcoma

LMU researchers reveal role of mutations in development of Ewing's sarcoma

Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-101 Phase 1 trial

Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-101 Phase 1 trial

UofL conducts Phase I research study for children with relapsed tumors

UofL conducts Phase I research study for children with relapsed tumors

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award